Autoimmune/Cholestatic/Biliary Diseases

Top Story

Ocaliva associated with collagen improvement in patients with PBC

Ocaliva associated with collagen improvement in patients with PBC
May 20, 2019
Meeting NewsVideo

VIDEO: Seladelpar effective for PBC, to be studied in NASH

April 27, 2019
VIENNA — In this exclusive video from the International Liver Congress 2019, Sujal Shah, MS, MBA, president and CEO of CymaBay Therapeutics, discusses the results…
Meeting NewsVideo

VIDEO: Pediatric cholestatic disease therapy improves bile acids, reduces pruritus

April 23, 2019
VIENNA — In this exclusive video from the International Liver Congress 2019, Patrick T. Horn, MD, PhD, chief medical officer of Albireo Pharmaceuticals, provides…
Meeting NewsVideo

VIDEO: Givosiran may ‘transform’ lives of patients with acute hepatic porphyria

April 20, 2019
VIENNA — In this exclusive video from the 2019 International Liver Congress, Akin Akinc, PhD, of Alnylam Pharmaceuticals, discusses results of a study in which…
More Headlines »
CME

Cirrhosis and Hepatic Encephalopathy – Managing Their Consequences and Complications

This activity is supported by an educational grant from Salix Pharmaceuticals, a division of Valeant Pharmaceuticals North America LLC.

Cirrhosis, or advanced fibrosis of the liver, can lead to serious health sequelae or death. However, substantial…
More »
GI Bookshelf

Question 28: I Have A Patient With Biliary-Type Pain, But No Other Evidence Of Bile Duct Disease (Normal Diameter Duct On Ultrasound, Normal Liver Function Tests). How Should Such A Patient Be Managed?

From Curbside Consultation in Endoscopy: 49 Clinical Questions, Second Edition
More »
Video
Meeting News

Pentax Medical shares new GI, biliary technology presented at DDW

June 22, 2018
More »